COVID-19: The Resident and Program Director Perspective
EPI Health has graciously supported the COVID-19 News and Resource Center.
On April 22nd, 2020, the Journal of Drugs in Dermatology, Derm In-Review, and the George Washington School of Medicine and Health Sciences hosted a live webinar to answer resident concerns during the global coronavirus pandemic. The webinar was moderated by Dr. Adam Friedman, Professor and Interim Chair of Dermatology a …
EPI Health has graciously supported the COVID-19 News and Resource Center.
On April 22nd, 2020, the Journal of Drugs in Dermatology, Derm In-Review, and the George Washington School of Medicine and Health Sciences hosted a live webinar to answer resident concerns during the global coronavirus pandemic. The webinar was moderated by Dr. Adam Friedman, Professor and Interim Chair of Dermatology a … Continue reading "COVID-19: The Resident and Program Director Perspective"
EPI Health has graciously supported the COVID-19 News and Resource Center.
Companies in the dermatology industry are playing a role in the fight against COVID-19. From researching possible treatments and vaccines to modifying production lines for essential products, the following is a listing of dermatology companies and their COVID-19 efforts:
AbbVie is researching whether its drug KALETRA� … 
The type of repair depicted in the photograph is a:
A. Rhombic flap
B. Nasolabial transposition flap
C. Rotation flap
D. Full-thickness skin graft
E. Island pedicle flap
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
EPI Health has graciously supported the COVID-19 News and Resource Center.
I, along with dermatology residents and dermatologists all over the country, have been watching the world leaders in our field as they try to keep a finger on the ever-changing pulse of the COVID-19 pandemic. For the dermatologist, we have either been forced into a technological world we had not yet fully embraced or we … 
Psoriasis involves a complex inflammatory cascade mediated by various cytokine effectors. Over the past fifteen years, treatment options have evolved to include biologic medications that provide targeted inhibition of various pathways. IL-23 has emerged as an important inflammatory cytokine in the pathogenesis of psoriasis. We continue our series, Therapeutic Cheat Sheet, with a closer look at IL- …